UDG Healthcare plc Revenue and Competitors
Estimated Revenue & Valuation
- UDG Healthcare plc's estimated annual revenue is currently $64.5M per year.
- UDG Healthcare plc's estimated revenue per employee is $201,000
Employee Data
- UDG Healthcare plc has 321 Employees.
UDG Healthcare plc's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Learning and Development | Reveal Email/Phone |
2 | Corporate Executive assistant to CEO, COO & CHRO | Reveal Email/Phone |
UDG Healthcare plc Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is UDG Healthcare plc?
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 9,000 people in 29 countries.
keywords:N/A
N/A
Total Funding
321
Number of Employees
$64.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
UDG Healthcare plc News
UDG Healthcare PLC. Report contents include. 1 Analysis of the Real World Evidence Solutions Market includes revenues, future growth,...
IQVIA, PAREXEL, Syneos Health, UDG Healthcare Plc (Ashfield), Trilogy Writing & Consulting, Covance, Freyr Solutions, Nucleus Global, Indegene, ICON,...
Ashfield (UDG Healthcare plc), InVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution,...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $72.2M | 321 | 18% | N/A |
#2 | $130.4M | 321 | N/A | N/A |
#3 | $132.4M | 321 | N/A | N/A |
#4 | $64.2M | 321 | 13% | N/A |
#5 | $98.3M | 321 | -10% | N/A |